Court rejects Trump-era EPA finding that weed killer safe

The active ingredient in the weed killer is not likely to cause cancer in humans according to the Trump administration.

The 9th US Circuit Court of Appeals ordered the EPA to reexamine its 2020 finding that there was no health risk for people who were exposed to it by any means.

The most widely used weed killer in the world is glyphosate. There are thousands of claims from people who say they got cancer because of their exposure to the weed killer.

The product will be available for purchase. A spokesman for the EPA said that officials are reviewing the 54-page ruling and will decide next steps.

The judge said the EPA's finding of no risk to human health was not supported by substantial evidence. She ruled that the EPA fell short of its obligations under the act because it failed to adequately examine the effects of the pesticide on animals and plants.

Critics said the EPA didn't fulfill its duties under the act. Friedland was nominated by former President Barack Obama.

The Center for Food Safety was one of the groups that challenged the decision.

Amy van Saun, senior attorney with the center, said that the decision gave voice to those who suffer from the disease.

She said that the EPA's 'no cancer' risk conclusion did not stand up to scrutiny. The court agreed that the EPA needed to make sure the safety of the threatened species was assured.

California and other states have listed it as a cancer risk and local governments across the country have restricted its use. The International Agency for Research on Cancer classified the chemical as likely to cause cancer.

The US residential lawn-and-garden marketplace will no longer be affected by the removal of the weed killer glyphosate from it.

The EPA's 2020 conclusion was based on a rigorous assessment of the extensive body of science, according to a statement from the company. The company believes that the EPA will continue to conclude thatGlyphosate can be used safely and are not harmful.

$4.7 billion was set aside by the company last year to deal with the claims that the weed killer caused cancer. The company took a huge charge for earlier rounds of litigation.

"EPA's failure to act on the science, as detailed in the litigation, has real-world adverse health consequences for farmworkers, the public and the environment." The agency's obstruction of the regulatory process will not be allowed to continue.